Sex-Dependent Regulation of Host Factors Influencing SARS-CoV-2 Infection and COVID-19 Disease
Sex-Dependent Regulation of Host Factors Influencing SARS-CoV-2 Infection and COVID-19 Disease
批准号:
10610459
负责人:
Montserrat C Anguera
金额:
$20.11万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-04-15 至 2024-03-31
关键词:
2019-nCoVACE2Acute Respiratory Distress SyndromeAffectAgeAlveolarAngiotensin IICD4 Positive T LymphocytesCOVID-19COVID-19 morbidityCOVID-19 mortalityCOVID-19 severityCOVID-19 susceptibilityCOVID-19 treatmentCellsCodeCoronavirusCoronavirus InfectionsDataDevelopmentDiseaseDisease OutbreaksDisease OutcomeDisease ProgressionDisease modelElementsEndothelial CellsEpigenetic ProcessEstrogen TherapyEstrogensExhibitsFatal OutcomeFemaleFutureGene DosageGenesGeneticGonadal Steroid HormonesHormonalHormone ResponsiveHormonesHumanHybridsImmuneImmune responseImmunityInfectionInflammationInflammatoryInflammatory ResponseInjuryIntegration Host FactorsLinkLungMacrophageMiddle East Respiratory SyndromeMorbidity - disease rateMusOutcomePathologyPathway interactionsPatternPeripheralPhenocopyPneumoniaPopulationPredispositionProductionPublicationsPulmonary PathologyRegulationRegulatory ElementResistanceSARS coronavirusSARS-CoV-2 infectionSeverity of illnessSex BiasSex DifferencesSignal TransductionSupplementationSystemTestingTranscriptTranscriptional ActivationTransgenic MiceType 2 Angiotensin II ReceptorVascular DiseasesViralVirusVirus DiseasesWild Type MouseWomanX ChromosomeX Inactivationage relatedagedburden of illnesscell typecoronavirus diseasecytokinehigh riskinsightlung repairmalemenmortalitymouse modelnovelnovel coronavirusnovel strategiespost SARS-CoV-2 infectionpreservationpreventpromoterreceptorrespiratoryresponsesevere COVID-19sextranscriptome sequencing
中文摘要
项目摘要
COVID-19是由SARS-CoV-2病毒引起的疾病,通常表现为肺炎,
严重影响进展为急性呼吸窘迫综合征(ARDS)。值得注意的是,男性似乎在
COVID-19导致严重或致命结局的风险显著更高,男性特异性偏斜也
与相关冠状病毒SARS-CoV和MERS一起观察。X染色体富含免疫相关的
基因,并且女性(XX)比男性(XY)产生更强的免疫应答。x染色体失活
(XCI)使性别之间的基因剂量效应正常化,我们以前发现免疫细胞
具有新的和动态的XCI机制,允许从失活的基因特异性转录激活,
X(Xi)以细胞类型特异性方式。值得注意的是,我们的初步数据表明,XCI的调节,在肺泡
2型(AT 2)细胞,SARS-CoV-2在肺中的主要靶点,也是肺中关键参与的细胞类型。
病毒损伤后的修复,在免疫细胞中看到的表型复制。因此,我们将测试新的假设
X连锁基因,包括免疫基因和ACE 2,以谱系特异性方式逃避XCI,
女性对COVID-19的相对抵抗力(目标1)。我们将检验我们的小说人性化的假设
ACE 2小鼠对SARS-CoV-2感染易感,将表现出性别差异,
老年小鼠的病理学(目的2)。总之,这些研究将进一步加深我们对
使男性易患COVID-19疾病,并将揭示降低疾病严重程度的新策略。
英文摘要
Project Summary
COVID-19, the disease caused by the SARS-CoV-2 virus, commonly presents as pneumonia, with those most
severely affected progressing to Acute Respiratory Distress Syndrome (ARDS). Notably, males seem to be at
significantly higher risk for severe or fatal outcomes from COVID-19, and male-specific skewing was also
observed with related coronaviruses SARS-CoV and MERS. The X chromosome is enriched for immunity-related
genes, and females (XX) mount stronger immune responses than do males (XY). X-chromosome Inactivation
(XCI) normalizes the gene dosage effect between the sexes and we have previously found that immune cells
have novel and dynamic XCI mechanisms that allow for gene-specific transcriptional activation from the inactive
X (Xi) in a cell-type specific manner. Notably, our preliminary data suggest the regulation of XCI in lung alveolar
type 2 (AT2) cells, the predominant target of SARS-CoV-2 in the lung and a cell type critically involved in lung
repair following viral injury, phenocopies that seen in immune cells. As such, we will test the novel hypothesis
that X-linked genes, including immune genes and ACE2, escape XCI in a lineage-specific fashion and contribute
to the relative resistance of females to COVID-19 (Aim 1). We will test the hypothesis that our novel humanized
ACE2 mice, which are susceptible to SARS-CoV-2 infection, will exhibit sex differences with resulting lung
pathologies in aged mice (Aim 2). Together, these studies will further our understanding of the mechanisms that
predispose males to COVID-19 disease and will reveal novel strategies to reduce disease severity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role for nuclear matrix proteins and DNA methylation for XCI maintenance in female lymphocytes
-
批准号:10660313
-
项目类别:
-
资助金额:$57.38万
-
财政年份:2023
-
负责人:Montserrat C Anguera
-
依托单位:
Sex-Dependent Regulation of Host Factors Influencing SARS-CoV-2 Infection and COVID-19 Disease
-
批准号:10451255
-
项目类别:
-
资助金额:$24.17万
-
财政年份:2022
-
负责人:Montserrat C Anguera
-
依托单位:
Elucidating the Role of Dynamic X-Chromosome Inactivation Maintenance in the Pathogenesis of Systemic Sclerosis
-
批准号:10703419
-
项目类别:
-
资助金额:$17.88万
-
财政年份:2022
-
负责人:Montserrat C Anguera
-
依托单位:
Elucidating the Role of Dynamic X-Chromosome Inactivation Maintenance in the Pathogenesis of Systemic Sclerosis
-
批准号:10511513
-
项目类别:
-
资助金额:$21.45万
-
财政年份:2022
-
负责人:Montserrat C Anguera
-
依托单位:
Gene regulation from the inactive X in activated B cells
-
批准号:10397666
-
项目类别:
-
资助金额:$50.57万
-
财政年份:2018
-
负责人:Montserrat C Anguera
-
依托单位:
Expression of X-linked autoimmunity genes in B cells during female-biased autoimmunity
-
批准号:9391172
-
项目类别:
-
资助金额:$20.13万
-
财政年份:2016
-
负责人:Montserrat C Anguera
-
依托单位:
Expression of X-linked autoimmunity genes in B cells during female-biased autoimmunity
-
批准号:9244999
-
项目类别:
-
资助金额:$24.15万
-
财政年份:2016
-
负责人:Montserrat C Anguera
-
依托单位:
Transcriptional Silencing of the X-chromosome
-
批准号:7155525
-
项目类别:
-
资助金额:$4.88万
-
财政年份:2005
-
负责人:Montserrat C Anguera
-
依托单位:
Transcriptional Silencing of the X-chromosome
-
批准号:7055733
-
项目类别:
-
资助金额:$4.6万
-
财政年份:2005
-
负责人:Montserrat C Anguera
-
依托单位:
国内基金
海外基金
登录
查看更多内容
ACE2/AGXT2信号轴在甲基异柳磷诱导斑马鱼神经发育异常过程中的作用机制研究
-
批准号:JCZRLH202600625
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
ACE2 Ser623磷酸化调控MED1促VSMCs功能损伤在移植血管重构中的作用及机制研究
-
批准号:2026JJ50619
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:翁春艳
-
依托单位:
AURKA介导ACE2磷酸化修饰调控内皮细胞衰老在低氧性肺动脉高压中的作用及机制研究
-
批准号:82570085
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:沈慧
-
依托单位:
牛蒡叶倍半萜成分群激活ACE2/Ang1-7/MasR轴调控血管内皮—周细胞互作促缺血性脑卒中血管正常化机制研究
-
批准号:82404910
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2024
-
负责人:郝单丽
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2细胞受体识别及其分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
ACE2通过AMPK/SIRT3调控线粒体代谢改善盐敏感性高血压肾脏纤维化的机制
-
批准号:82460087
-
项目类别:地区科学基金项目
-
资助金额:33.00万元
-
批准年份:2024
-
负责人:赵宇
-
依托单位:
铁皮石斛通过肠道 ACE2 修复 Trp/GPR142 介
导“肠-胰岛 ”轴血糖调控功能的降糖机制研
究
-
批准号:Y24H280055
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:颜美秋
-
依托单位:
人类ACE2变构抑制剂的成药性及其抗广谱冠状病毒感染的机制研究
-
批准号:82330111
-
项目类别:重点项目
-
资助金额:220万元
-
批准年份:2023
-
负责人:刘刚
-
依托单位:
CAFs来源的外泌体负性调控ACE2促进肾透明细胞癌癌栓新辅助靶向耐药的机制研究
-
批准号:82373169
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:顾良友
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2受体识别及细胞入侵机制研究
-
批准号:32300137
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:陈静
-
依托单位: